3 Top Ranked Stocks Doling Out Sizable Dividends

When looking for a nice dividend stock, one should have an elaborate set of criteria to be met.  Double digit dividend yields are tempting, but you should do more research to make sure that your investments are dependable.  After all, a 30% dividend yield won’t be worth much if the stock price ends up going to $0.  

Make sure that whatever you’re investing in has a nice valuation so that you can worry less about about the negativity which volatility can cause.  After all, you don’t want to get caught up in bumpy trading when you buy a stock with a high price tag.  Fortunately, we have found three top ranked stocks with hefty yields you can depend on.  Each of these stocks have earned a “B” for value in our Style Scores.  They have all done well in outperforming our EPS consensus estimate as well.  The three stocks below deserve your consideration if you’re looking for some valuable stocks with considerable yields.

Guess Inc-(GES – Analyst Report)
Guess designs and sells casual apparel across the globe.  The fashion brand did well to beat our revenues consensus last quarter.  Guess is a Zacks Rank #1 (Strong Buy).  It doles out a generous 4% yield to investors. 
Guess has a “B” for value in our Style Scores, and for good reason.  It trades at a price to book of 1.77, while the industry as a whole trades at a 2.36. The company also has a price to sales of just 0.81.  A price to sales under one may suggest that there is value present.  Guess has an Enterprise value to EBITDA of just 6.09, and is way ahead of the industry with regards to this valuation. 
Guess has beaten our EPS consensus estimate in each of the last four quarters. It has managed to surpass our consensus by an average of 65% per quarter.  The corporation reports its earnings on 12/2/15.
AbbVie Inc-(ABBV – Analyst Report)
AbbVie is a research based biopharmaceutical company with a global presence.  The company strives to create innovative therapies and drugs to treat serious diseases of the kidney and liver.  The company also focuses on advancing treatments for cancer.  AbbVie is a Zacks Rank #2 (Buy).  The stock has a yield of 3.64%. 
AbbVie has some nice growth and value characteristics.  For one, the stock has a PEG of just 0.91, and a forward PE of 13.04.  ABBV also has an earnings yield of 7.68%.  Sales are projected to grow by 15% this year.  The company’s EPS is expected to be 28.52% higher compared to last year’s earnings.  The biopharmaceutical corporation has beaten our EPS consensus in each of the last four quarters and it reports earnings on 10/30/15.
Darden Restaurants, Inc-(DRI – Analyst Report)

Print Friendly, PDF & Email

Author: Travis Esquivel

Travis Esquivel is an engineer, passionate soccer player and full-time dad. He enjoys writing about innovation and technology from time to time.

Share This Post On

Submit a Comment

Your email address will not be published. Required fields are marked *